Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXI4ON
|
||||
Drug Name |
4-(4-methoxyphenyl)-2-methyl-7-(3-(4-(4-(trifluoromethyl)phenyl)piperazin-1-yl)propoxy)-1,2,3,4-tetrahydroisoquinoline
|
||||
Synonyms |
CHEMBL232010
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C31H36F3N3O2
|
||||
Canonical SMILES |
COc1ccc(cc1)C2CN(C)Cc3cc(OCCCN4CCN(CC4)c5ccc(cc5)C(F)(F)F)ccc23
|
||||
InChI |
InChI=1S/C31H36F3N3O2/c1-35-21-24-20-28(12-13-29(24)30(22-35)23-4-10-27(38-2)11-5-23)39-19-3-14-36-15-17-37(18-16-36)26-8-6-25(7-9-26)31(32,33)34/h4-13,20,30H,3,14-19,21-22H2,1-2H3
|
||||
InChIKey |
WLVVWVWAWIFTAL-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Histamine H3 receptor | Target Info | [1587926] | ||
Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
NetPath Pathway | TCR Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.